Emergency Number

This section contains details of Shalby Hospital’s results announcements, business presentations along with relevant information and disclosures of the company.


To receive email alerts from Investor Relations, click on Subscribe.


Investors

RTP HY1 HY2
FY 2018-19

 

Annual Return
FY 2017-18
FY 2018-19
  • Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at Edelweiss India Conference (Feb’18):

 

  • Dr. Vikram Shah – Chairman & Managing Director, Shalby Limited at IIFL Enterprising India IX-2018 (Feb’18):

  • A Special Episode in CNBC Awaaz – Incredible Journey – Rising stars

Statement of Investor Complaints – Q4 FY 2017-18
Share Capital Audit – 31-03-2018
Compliance Certificate under Reg. 7(3) of LODR
Press Release – MoU with Sen Sok Intl Hospital, Cambodia
Certificate under Regulation 40(10) of SEBI LODR
Joint Replacement Surgeries under Mukhyamantri Amrutam Yojana
Change in CIN
Schedule of Investor / Analyst Meet
Schedule of Investor / Analyst Meet – 27-04-2018
Intimation Conference Call
Intimation Appointment of CDSL as designated depository
Collaboration with Berkeley Health Education
Investor/Analyst meeting with Motilal Oswal Securities Limited
Investors meet/UBS India- Midcap conference
Resignation of Chief Executive Officer of the Company
Intimation Analyst meet HDFC Securities 26-06-2018
Updates relating to resignation of CEO
Man of the Year Award – Dr. Vikram Shah
Intimation Analyst meet – 26-06-2018
Intimation Analyst meet - 27-06-2018
Intimation Analyst meet - 02-07-2018
Intimation Analyst meet – 06-07-2018
Intimation Liver Disease and Transplantation
Karvy Reconciliation Report
Investor Grievance report
 Intimation of AGM
 Intimation of Book closure
 AGM Notice & Annual Report 2017-18
 Newspaper Ad. AGM, Book closure & E-voting
 Outcome of AGM
 Voting Results
 Shalby Press Release - Ovarian Mass Removal Jaipur
 Credit Rating ICRA Reg 30 LODR
 Reg 30 Orthotrends 2018 Chandigarh
 Intimation under Regulation 30 of SEBI LODR-concall with Edelweiss
 Investor Grievance Report Q2 FY 2018-19
 Share Capital Audit Q2 FY 2018-19
 Compliance Certificate 7(3) – 30-09-2018
 Certificate under Regulation 40(10) of SEBI LODR –H1 FY 2018-19
 Pre Accreditation Entry level NABH at Shalby Surat
 Intimation for Conference call
 Submission of newspaper AD – Notice of Board Meeting
 Pre-Accreditation Entry level NABH at Shalby Naroda
 Newspaper ad for Issue of Duplicate Shares
 Intimation Analyst Meet – Nalanda Capital
 Intimation participation in IDFC Investor Conference
 Investor conference Kotak
 Intimation Issue of Duplicate Shares
 Press Release Kolkata
 Intimation Transfer of operations Karvy
 Medical Value Travel Specialist Hospital Award 2018
 Best hospital for Medical Tourism in Gujarat Award
 Share Capital Audit Q3 FY 2018-19
  Intimation of Investor Analyst Concall
Intimation of Conference Call
Intimation Analyst meet - DSP BlackRock Investment
 Newspaper ad for Q3 FY 2018-19 Results

Financial Year Q1 Q2 Q3 Q4
2017-18
2018-19
2019-20
Financial Year Q1 Q2 Q3 Q4
Result Transcript Result Transcript Result Transcript Result Transcript
2017-18
2018-19
2019-20

 

 

Financial Year Q1 Q2 Q3 Q4
Board Meeting Intimation News Paper Ad. Intimation News Paper Ad. Intimation News Paper Ad. Intimation News Paper Ad.
2017-18
2018-19
2019-20

 

General Meeting Intimation Book closure / Record date Advertisement Outcome Voting Result
14th AGM – 17-09-2018
15th AGM – 26-08-2019

 

 

Registered & Corporate Office

Shalby Limited

Opposite Karnawati Club,

Sarkhej Gandhinagar Highway,

Near Prahlad Nagar Garden,

Ahmedabad – 380 015, Gujarat, India

Phone: +91 79 4020 3000

Fax :+91 79 4020 3120

CIN : L85110GJ2004PLC044667

 

Listed at NSE & BSE

Listing Date    December 15, 2017

Scrip Code : NSE – SHALBY

BSE – 540797

 

ISIN     INE597J01018

Face Value of Shares  ` 10

Outstanding Shares 108,009,770

Financial Year ending  March 31 of every year

Grievance Redressal

The Shareholders may forward their queries/grievances to the Company at the following address :

Compliance Officer :

Mr. Jayesh Patel

Company Secretary and Compliance Officer

Email : Companysecretary@shalby.in

Tel. No : +91 79 4020 3000

Fax No : +91 79 4020 3120

Website : www.shalby.org

Registrar & Transfer Agent

Karvy Fintech Private Limited

Unit : Shalby Limited

Karvy Selenium, Tower B,

Plot 31 – 32, Gacchibowli

Financial District, Nanakramguda,

Serilingampally, Hyderabad – 500 032,

Telangana, India

Tol Free No.:18003454001

Tel: +91 40 6716 2222

Fax: +91 40 2343 1551

Investor Grievance E-mail: einward.ris@karvy.com

Financial Year Q1 Q2 Q3 Q4
2017-18
2018-19
2019-20
Financial Year Q1 Q2 Q3 Q4
2017-18  
2018-19
2018-19

 

Financial Year Q1 Q2 Q3 Q4
2017-18
2018-19
2019-20
Annual Reports
2016-17 2017-18 2018-19
Shalby Limited
Subsidiary Companies
Shalby (Kenya) Limited
Yogeshwar Healthcare Ltd.
Vrundavan Shalby Hospitals Ltd.
Shalby International Ltd.
Griffin Mediquip LLP